Dying of amyotrophic lateral sclerosis

Objective To describe health care service utilization and cost for decedents with and without amyotrophic lateral sclerosis (ALS) in the last year of life. Methods Using linked health administrative data, we conducted a retrospective, population-based cohort study of Ontario, Canada, decedents from 2013 to 2015. We examined demographic data, rate of utilization, and cost of health care services in the last year of life. Results We identified 283,096 decedents in Ontario, of whom 1,212 (0.42%) had ALS. Decedents with ALS spent 3 times as many days in an intensive care unit (ICU) (mean 6.3 vs 2.1, p < 0.001), and twice as many days using complex continuing care (mean 12.7 vs 6.0, p < 0.001) and home care (mean 99.1 vs 41.3, p < 0.001). A greater percentage of decedents with ALS received palliative home care (44% vs 20%, p < 0.001) and palliative physician home visits (40% vs 18%, p < 0.001) than decedents without ALS. Among decedents with ALS, a palliative physician home visit in the last year of life was associated with reduced adjusted odds of dying in hospital (odds ratio 0.65, 95% confidence interval 0.48–0.89) and fewer days spent in the ICU. Mean cost of care in the last year of life was greater for those with ALS ($68,311.98 vs $55,773.48, p < 0.001). Conclusions In this large population-based cohort of decedents, individuals with ALS spent more days in the ICU, received more community-based services, and incurred higher costs of care in the last year of life. A palliative care physician home visit was associated with improved end of life outcomes; however, the majority of patients with ALS did not access such services.

[1]  K. Schellenberg,et al.  Hospital utilization for patients with amyotrophic lateral sclerosis in saskatoon, Canada , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[2]  D. Manuel,et al.  Associations between physician home visits for the dying and place of death: A population-based retrospective cohort study , 2018, PloS one.

[3]  Jeremy M. Shefner,et al.  Profile of medical care costs in patients with amyotrophic lateral sclerosis in the Medicare programme and under commercial insurance , 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[4]  R. Moorin,et al.  Earlier Initiation of Community-Based Palliative Care Is Associated With Fewer Unplanned Hospitalizations and Emergency Department Presentations in the Final Months of Life: A Population-Based Study Among Cancer Decedents. , 2017, Journal of pain and symptom management.

[5]  J. Semmens,et al.  The impact of community-based palliative care on acute hospital use in the last year of life is modified by time to death, age and underlying cause of death. A population-based retrospective cohort study , 2017, PloS one.

[6]  J. Harrison,et al.  Early Palliative Care Reduces End-of-Life Intensive Care Unit (ICU) Use but Not ICU Course in Patients with Advanced Cancer. , 2017, The oncologist.

[7]  W. Wodchis,et al.  Palliative care delivery across health sectors: A population-level observational study , 2016, Palliative medicine.

[8]  L. Zinman,et al.  The economic impact of amyotrophic lateral sclerosis: a systematic review , 2015, Expert review of pharmacoeconomics & outcomes research.

[9]  Walter P. Wodchis,et al.  The Health Care Cost of Dying: A Population-Based Retrospective Cohort Study of the Last Year of Life in Ontario, Canada , 2015, PloS one.

[10]  L. Zinman,et al.  Economic burden of amyotrophic lateral sclerosis: A Canadian study of out-of-pocket expenses , 2014, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

[11]  P. Austin,et al.  Impact of community based, specialist palliative care teams on hospitalisations and emergency department visits late in life and hospital deaths: a pooled analysis , 2014, BMJ : British Medical Journal.

[12]  E. Bruera,et al.  Impact of timing and setting of palliative care referral on quality of end‐of‐life care in cancer patients , 2014, Cancer.

[13]  P. Hogan,et al.  Cost of illness for neuromuscular diseases in the United States , 2014, Muscle & nerve.

[14]  S. Patten,et al.  Diagnostic data for neurological conditions in interRAI assessments in home care, nursing home and mental health care settings: a validity study , 2013, BMC Health Services Research.

[15]  Y. Do,et al.  Association between referral-to-death interval and location of death of patients referred to a hospital-based specialist palliative care service. , 2013, Journal of pain and symptom management.

[16]  D. Currow,et al.  Early admission to community-based palliative care reduces use of emergency departments in the ninety days before death. , 2013, Journal of palliative medicine.

[17]  Walter P. Wodchis,et al.  Guidelines on Person-Level Costing Using Administrative Databases in Ontario , 2013 .

[18]  P. Jennum,et al.  Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study , 2013, Journal of Neurology.

[19]  P. Andersen,et al.  EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force , 2012, European journal of neurology.

[20]  Alona Muzikansky,et al.  Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.

[21]  S. Dy,et al.  Did Ontario's end-of-life care strategy reduce acute care service use? , 2010, Healthcare quarterly.

[22]  Paul McCrone,et al.  Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial. , 2009, Journal of pain and symptom management.

[23]  Gordon H Guyatt,et al.  Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.

[24]  A. Kübler,et al.  Palliative care and circumstances of dying in German ALS patients using non‐invasive ventilation , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[25]  S. Enguídanos,et al.  Increased Satisfaction with Care and Lower Costs: Results of a Randomized Trial of In‐Home Palliative Care , 2007, Journal of the American Geriatrics Society.

[26]  T. Benstead,et al.  ALS Incidence in Nova Scotia Over a 20- Year-Period: A Prospective Study , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[27]  C. Earle,et al.  Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology , 2006, Palliative medicine.

[28]  L. McCluskey,et al.  A Cost Comparison of Hospice Care in Amyotrophic Lateral Sclerosis and Lung Cancer , 2006, The American journal of hospice & palliative care.

[29]  L. McCluskey,et al.  Medicare hospice referral criteria for patients with amyotrophic lateral sclerosis: a need for improvement. , 2004, Journal of palliative medicine.

[30]  I. Higginson,et al.  Effect of a palliative home care team on hospital admissions among patients with advanced cancer , 2003, Palliative medicine.

[31]  C. Earle,et al.  Identifying potential indicators of the quality of end-of-life cancer care from administrative data. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  W. Johnston,et al.  The final month of life in patients with ALS , 2002, Neurology.

[33]  O. Hardiman,et al.  Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey , 2001, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[34]  S. Felder,et al.  Health care expenditure in the last months of life. , 2000, Journal of health economics.

[35]  B. Leff,et al.  House calls. , 1998, The New England journal of medicine.

[36]  J. Lubitz,et al.  Trends in Medicare payments in the last year of life. , 1993, The New England journal of medicine.

[37]  C. Warlow,et al.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[38]  A. Hudson,et al.  The incidence of amyotrophic lateral sclerosis in southwestern Ontario, Canada , 1986, Neurology.